Background Specific proteins have traditionally been analyzed using methodologies such as immunonephelometry on specialized analyzers. It is now possible to perform specific protein testing on clinical chemistry analyzers using immunoturbidimetry. Performance characteristics of turbidimetric assays for eight common specific proteins were evaluated against a nephelometric method.
Introduction
There are a variety of analytes generally classi¢ed as 'speci¢c proteins'that have wide ranging clinical utility. In the past, speci¢c proteins were analyzed using specialized, somewhat esoteric methods, such as radial immunodi¡usion, immunoelectrophoresis, or dedicated immunonephelometers or immunoturbidimeters. 1 It is now possible to use immunoturbidimetric methodology to analyze a wide variety of speci¢c proteins on general-purpose clinical chemistry systems.
Automation of speci¢c protein testing o¡ers rapid analysis, random access, high volume testing, and cost reduction. Shifting of speci¢c protein analysis to a clinical chemistry platform may result in reduced turn around time for these tests and can allow for consolidation of testing and elimination of more specialized individual analyzers. Before switching to immunoturbidimetric tests for speci¢c proteins, a laboratory should consider whether the analytical performance of this methodology is equivalent to the more traditional techniques that are commonly used and whether they meet medical needs. The Abbott Architect ci8200 analyzer was installed at Middlemore Hospital in November 2003 and resulted in the consolidation of chemistry and immunoassay platforms, greatly improving the laboratory e⁄ciency with a marked improvement in turn around times.To achieve further consolidation of testing, it was necessary to evaluate the performance of speci¢c protein assays on the ci8200 system.
The assays evaluated were CRP, IgA, IgG, IgM, C3, C4, haptoglobin, and transferrin. The IgA, IgG, IgM, C3, C4, haptoglobin, and transferrin immunoturbidimetric assays were compared to the same tests performed by an automated immunonephelometric analyzer, Beckman Immage, that was in use as the routine method. Abbott and Sentinel CRP assays were compared to a Roche immunoturbidimetric assay performed on the ci8200 that was in use as the routine method.
Materials and methods

Assays and analyzers
Assays for CRP, IgG, IgA, IgM, C3, C4, haptoglobin, and transferrin were performed using Architect ci8200 (Abbott Laboratories, USA) and Beckman Immage (Beckman-Coulter Diagnostics, USA) analyzers. CRP assays were compared on the ci8200 using reagents from Abbott Laboratories (USA) , Sentinel (Italy), and Roche (New Zealand).
Specimens
Residual patient specimens submitted for routine testing for speci¢c proteins were used in this study. Approval for this use was given by the Auckland Regional Ethics Committee. The patient specimens were serum or plasma samples as speci¢ed as acceptable for analysis by the assay package inserts. BioRad Liquichek Immunology controls were used. Both fresh and frozen specimens were assayed on the same day for both the comparative and test methods.
Precision
The precision study followed Clinical and Laboratory Standards Institute (CLSI, formerly NCCLS) EP5, Evaluation of Precision Performance of Quantitative Measurement Methods. 2. Both within-run and total (day-to-day) precision were calculated for the ci8200 assays.Within run precision was based on 20 replicates of selected samples per analytical run. Total precision was based on 20 replicates (2 replicates in each of two analytical runs per day) over ¢ve days. Desirable speci-¢cations for imprecision were obtained from intra-individual biological variability ( 1 2 CVi) of the analytes as summarized by Westgard in http://www.westgard. com/biodatabase1.htm.
Linearity
The linearity study followed CLSI EP6, Evaluation of the Linearity of Quantitative Measurement Procedures. 3 The highest concentration calibrators were serially diluted with saline and replicates (n ¼ 4) of each dilution were tested to evaluate the observed linear range in comparison to the ci8200 manufacturer's reportable range claim. The observed results were compared to the expected (theoretical) results for each dilution and were evaluated against in-house speci¢cations for percent recovery, either in terms of recovery or absolute analyte concentration, whichever was greater.
Limit of detection (LoD)
Twenty replicates of saline and the lowest concentration calibrator were tested and the mean and SD were calculated. The LoD was estimated as the mean concentration of the saline sample plus 2 SD of the calibrator replicates.
Functional sensitivity
A range of low-level specimens were tested. Replicates (n ¼ 20) of specimens were tested for IgA, IgG, CRP, or hsCRP and the means, SDs, and CVs were calculated. The analyte concentrations (X axis) were plotted against the % CV (Y axis). The plots were extrapolated if necessary to estimate the concentration at which CV ¼ 20%. Functional sensitivity is de¢ned as the concentration at which the CV equals 20%, which is also de¢ned as the Limit of Quantitation (LoQ) in the ci8200 package inserts.
Accuracy
A reference standard, European Reference Material (ERM)-DA470 (CRP, IgG, IgA, IgM, C3, C4, haptoglobin, transferrin) was tested. Target values for DA470 were provided using unweighted means from 3--14 reference laboratories using turbidimetry (C3, C4, IgA, IgG, IgM, CRP), nephelometry (C3,C4, IgG, IgA, IgM, CRP) and radial immunodi¡usion (haptoglobin, transferrin, C3, C4, IgG, IgA, IgM, CRP), as stated on the analysis sheet from the Institute for Reference Materials and Measurements. Observed values were compared to the target values stated for the ERM-DA470.
Method comparison
The method comparison study followed CLSI EP9, Method Comparison and Bias Estimation Using Patient Samples. 4. A series of 2005 RIQAS (Randox International Quality Assurance Scheme) pro¢ciency testing (PT) survey samples were tested (2005 Cycles 31/1, 32/ 1, 32/2, and 32/3). Individual target values for the PT samples were determined by methodology (i.e. turbidimetric or nephelometric) consensus across RIQAS participants and the mean across all survey samples was calculated. Observed values were compared to the target values determined by RIQAS. In addition, patient specimens were tested by both the Immage (comparative method) and the ci8200. For CRP, IgG, IgA, and IgM, very high concentration specimens and saline dilutions were tested to assess antigen excess conditions (prozone phenomenon). Method comparison results were subjected to Altman and Bland di¡erence plots as well as Passing-Bablok regression analysis using MedCal software (www.medcal.be). 5 
Workflow
The analytical throughput of the ci8200 was measured and compared to the throughput of the Immage. For the ci8200, a typical peak workload of specimens (n ¼ 50 samples; 600 tests) consisting of routine chemistry tests was evaluated for throughput (time to ¢rst and last test result). Typical speci¢c protein test requests (4% additional tests, n ¼ 25) for this workload and their impact on throughput were evaluated. The consolidated chemistry and speci¢c protein test workload consisted of 50 samples with a total of 600 routine chemistry tests and 25 speci¢c protein tests.
Results
Precision, LoD and functional sensitivity Table 1 summarizes the precision, LoD and functional sensitivity data for the ci8200 assays. For each assay, the observed total % CV meets the recommended precision target based on the intra-individual biological variability of the analytes. 6 . For total precision, all CVs were below 2% except for IgM (low level control CV ¼ 2.4%) and Sentinel hsCRP (mid level control CV ¼ 2.3%). The observed precision was comparable or Linearity Table 2 summarizes the observed linearity for the ci8200 assays. Linearity, judged by the observed recovery of analyte at each of eight concentrations, was acceptable for all assays. Linearity recovery speci¢cations were either 710% of the target value or, at low concentrations, a stated maximum allowable concentration. In addition, the manufacturer's claimed linearity was veri¢ed for each of the ci8200 speci¢c protein assays and the Sentinel CRP and hsCRP assays. Package insert claims are based on the highest concentration calibrator tested by the manufacturer at time of generation of the insert data. The actual concentration of the high calibrator may vary from lot to lot of calibrator. In some cases, the calibrator tested had a higher concentration than that cited in the package insert. The linearity samples spanned the dynamic range of each assay.
Accuracy Table 3 lists recovery data observed for analysis of the ERM-DA470 reference material. Results for IgG, IgA, IgM, haptoglobin, C3 and C4 were within 5% of target for both the ci8200 and Immage. Results for CRP were within þ /À10% of target for Abbott, Sentinel and Roche assays. Table 3 also summarizes the comparison study conducted using RIQAS pro¢ciency survey specimens.
Method comparison
Comparison of analyte results with target values for each of the analytes varied between ci8200 and Immage, but all results were within 710% of target. The Abbott, Sentinel, and Roche CRP assays were all within 710% of the mean value for the turbidimetric users group. Table 4 summarizes the method comparison data for the Abbott, Sentinel, and Roche CRP assays all performed on the Architect ci8200, and for the other analytes performed on the ci8200 and the Beckman Immage. The Roche CRP and Beckman Immage tests were de¢ned as the comparative methods. Regression coe⁄cients were 0.99 for all assays except C4. The regression coe⁄cient for C4 was lower using only frozen samples (r 2 ¼0.92) compared with fresh samples (r 2 ¼0.96). Several samples stored at À201C prior to analysis of C4 demonstrated elevated results on the Immage compared to the ci8200. Samples were centrifuged, checked for clots, and retested on both the ci8200 and Immage. Retest and initial results were comparable on the ci8200 whereas retest results on the Immage decreased compared to initial results and were more comparable to ci8200 results (data not shown). Data for C4 assay on fresh and frozen samples are shown separately in Table 4 . The scatter plot in Figure 1 is for fresh samples only. The regression line intercepts for individual analytes, which serve as estimates of method bias, were not remarkable. Di¡erence plots are shown in Figure 1 .
Antigen excess
CRP, IgG, IgA, and IgM are analytes typically noted for the potential to exhibit the antigen excess phenomenon due to paraproteins for the immunoglobulins and due to an extreme acute phase response for CRP. The highest concentration of each analyte tested in our study is shown as the upper limit of 'Range of Results' in Table 4 .
When tested undiluted, the high concentration samples resulted in either appropriate error £ags (greater than the dynamic range of the assay) or very high concentration results, bordering on the upper linearity limits. In cases in which the undiluted samples produced error £ags, dilution successfully brought the concentrations back into the linear ranges and yielded results consistent with analyte concentrations. In cases in which undiluted samples produced very high results, the values for the diluted samples agreed with the undiluted values. When values were available for more than one dilution, there was good agreement between results. Neither ci8200 nor Immage exhibited the antigen excess e¡ect for the analytes and samples tested.
Workflow
The impact of consolidating speci¢c protein testing with the routine laboratory work£ow was evaluated on the ci8200. First, a typical peak workload of specimens (n ¼ 50 samples; 600 tests), consisting of routine chemistry tests, was evaluated for throughput. The 
Discussion and conclusion
Speci¢c protein assay is becoming ever more prevalent with the availability of analyzers and reagents that make it feasible to perform testing in routine clinical laboratories instead of sending specimens to more specialized reference laboratories. Laboratories have at least three options: (1) perform speci¢c protein assays on a dedicated instrument such as a nephelometer, or (2) use a general purpose clinical chemistry analyzer and immunoturbidimetric reagents, or (3) use a combination of both types of systems if this approach best meets the needs of the facility. This study was conducted to evaluate the performance of several immunoturbidimetric speci¢c protein tests on a high volume routine clinical chemistry system, the Architect ci8200, in comparison to a common dedicated immunonephelometric system, the Beckman Immage. The ci8200 immunoturbidimetric tests performed well based on the observed precision, linearity, LoD, functional sensitivity, accuracy, and work£ow characteristics. We consider them to provide clinically acceptable results. An unexpected result in our study was the determination of functional sensitivity lower than LoD for three assays: CRP Sentinel, IgG and IgA. The measured values for an assay's LoD and functional sensitivity depend upon the speci¢c protocol used. The elevated LoD results obtained in our study were likely in£uenced by such factors as the selection of a calibrator which greatly exceeds the saline blank measurement, resulting in a larger standard deviation, and the asymmetrical distribution of blank values resulting from the analyzer only reporting non-negative results. Recognizing these issues, the NCCLS has recently approved a revised protocol (EP17A) 7 for determination of LoD and functional sensitivity.
The enhanced functional sensitivity of Abbott's IgA assay potentially provides improved ability to detect immune compromised patients. The vendor's stated functional sensitivity of the IgA method (0.03g/L) Figure 1 Comparison of specific protein methods using difference plots. The solid line indicates the mean difference between methods, and the dashed line indicates the upper and lower 95% confidence limits of the difference between methods allows us to alert clinicians with this result annotation: 'This patient may have selective or complete IgA de¢ciency and may be at risk of anaphylaxis from the transfusion of blood or blood products containing IgA'. The ci8200 tests compared well with the corresponding Beckman Immage assays, based on the observed correlation coe⁄cients. The performance of the Abbott and Sentinel CRP was also acceptable and agreed very well with the Roche immunoturbidimetric CRP assay. The correlation coe⁄cients for the assays ranged from 0.962--0.999 and regression line slopes from method comparison studies ranged from 0.82--1.16. The wide SD limits shown in Figure 1 for CRP are in£uenced by large proportional di¡erences at low values (1--2 mg/L) and are probably an artifact of whole-number reporting for CRP. Interestingly, although analysis of both the ERM-DA470 reference material and 2005 RIQAS pro¢ciency samples yielded results within10% of the speci¢ed target for each assay, method comparison performance on patient samples for CRP, C3, C4, IgA and IgM was inferior to this, suggesting that further improvement in method standardization is still bene¢cial for these assays. For IgA and IgM the method bias at higher analyte concentrations exceeded10%, but this was considered clinically unimportant. For other analytes, visual examination of regression and di¡erence plots suggest that the bias observed in method comparison studies was uniform across the analyte range tested. Although the slopes from the method comparison studies in some cases lay outside the desirable range (slope 0.9--1.1), this is not unexpected when comparing immunoassays due to factors such as di¡erences in methodology and antibody speci¢city, and the absence of a reference method. Slope values ranging from 0.90--1.10 for two methods are generally considered acceptable and results for the same specimens analyzed by the methods would be considered clinically equivalent. In these cases, a common reference range would probably be suitable for both methods. When slope values are o0.90 or 41.10, values may need to be interpreted using method-speci-¢c reference ranges.
A few similar comparison studies have been conducted. Using CRP and hsCRP, comparison of turbidimetric methods with nephelometric methods have been conducted using analytical platforms from Olympus, Roche, Beckman and Behring. 8--11 These authors concluded that turbidimetric and nephelometric methods compared closely in analytical performance. Methods were precise and correlated well, although in some cases the nephelometric results were lower than the turbidimetric results and authors have argued for improved method standardization. 8 Ledue et al. developed turbidimetric assays for fourteen speci¢c proteins for a generalpurpose clinical chemistry analyzer (Hitachi 912) and compared their performance to nephelometric assays (Dade Behring BNII). 1 The turbidimetric tests were proved to be well suited for routine clinical use and correlated well with the nephelometric tests (r40.97).
The Immage appears to be more susceptible to interference from microclots, resulting in a falsely increased measured value, than the ci8200. Both fresh and frozen patient specimens were used in the C4 method comparison study. In cases in which the results were clearly discordant, examination of the specimens revealed the presence of protein precipitates. The Immage does not have a clot detection system whereas the ci8200 employs a pressure monitoring clot detection system. Recentrifugation of the samples improved agreement between the methods. Based on these observations, sample handling and storage for C4 specimens is being examined in our laboratory.
The prozone phenomenon is a common challenge with immunoassay. All samples that may exhibit the prozone phenomenon for CRP, IgG, IgA, and IgM were detected and accurately quanti¢ed. In fact, all samples with very high analyte concentrations were successfully £agged by the ci8200 and appropriate dilutions of these samples yielded accurate values.
A practical advantage of the ci8200 is that speci¢c protein testing can be consolidated by performing it on the Abbott Architect system, instead of maintaining a separate analyzer. This test consolidation also eliminates the need for the manual processing (e.g. labeling an aliquot tube, pouring o¡ the aliquot, transporting aliquots to a separate analyzer, etc.), potentially reducing the chance for errors (e.g. mislabeling of aliquot tubes, misplacing aliquots, ordering the wrong tests for aliquots, etc.). Speci¢c protein tests can be performed using the specimen collected for routine clinical chemistry assays and, depending on physician orders, this may result in a decrease in the number of specimen tubes and the volume of blood drawn from a patient. In general, test consolidation by use of an integrated system can improve laboratory e⁄ciency.
In summary, the ci8200 speci¢c protein assays are easy to use, give reliable results, and allow consolidation of speci¢c protein assays on a single integrated system. This improves laboratory e⁄ciency with decreased turnaround time of assay results, decreased sample volume, decreased sample splitting, and improved labour utilization. The assays also correlate well with the Beckman Immage nephelometric assays. We conclude that the ci8200 speci¢c protein immunoturbidimetric assays are suitable for routine use and provide an alternative to Immage immunonephelometric assays.
